Journal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 8, Issue 7, Pages 815-829Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERI.10.49
Keywords
antimicrobial resistance; bacteremia; bloodstream infections; community-acquired infections; nosocomial infections; sepsis
Funding
- Ministerio de Sanidad y Consumo, Institut de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases [RD06/0008]
Ask authors/readers for more resources
Bloodstream infection (BSI) is a frequent complication of invasive infections. The presence of bacteremia has therapeutic and prognostic implications. Here we review recent changes in the epidemiology, diagnosis and treatment of BSI (excluding candidemia). The evidence of the impact of healthcare-association in many community-onset episodes and the increase in drug-resistant pathogens causing BSI in the community and hospitals is reviewed. The emergence of molecular methods as an alternative tool for the diagnosis of BSI and novel aspects of clinical management, particularly of some multidrug-resistant organisms. Several quality indicators related to the diagnosis and management of bacteremia in hospitals are proposed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available